Assessment of Improved Diagnostic Strategies for the Early Identification of Endometrial Malignancy

Dr. Zamin Abbas¹, Dr. Haroon Raja², Dr. Obaidullah Khan¹, Dr. Hub-e-Ali¹Dr. Shikoh Naz¹, Dr. Tabassum Raja¹  

¹UHS Lahore

²Assistant professor, Department of Radiotherapy & Nuclear Medicine Dr Faisal Masood Teaching Hospital Sargodha.

ABSTRACT:

Background: Endometrial carcinoma is a prevalent gynecological malignancy, with early diagnosis being crucial for improving patient outcomes. This abstract explores recent advancements in the field of early detection and diagnosis of endometrial carcinoma, focusing on the emergence of promising biomarkers and innovative imaging techniques.

Aim: The aim of our current review is to offer an overview of the latest developments in early detection and diagnosis of endometrial carcinoma, with a specific focus on promising biomarkers and cutting-edge imaging techniques. The ultimate goal is to enhance our understanding of this disease and improve patient prognosis through early intervention.

Methods: The study was conducted from Deceember 2022 to Deceember 2023. A comprehensive literature review was conducted, encompassing studies and research articles from peer-reviewed journals, databases, and clinical trials, published over the last five years. The selected publications were critically analyzed to identify key advancements in initial detection and diagnosis of endometrial carcinoma, with a focus on biomarkers and imaging techniques.

Results: The review highlights the emergence of novel biomarkers, such as microRNAs and specific protein markers, which have shown promise in early endometrial carcinoma detection. Additionally, the use of advanced imaging techniques, including magnetic resonance imaging (MRI) and positron emission tomography (PET), has demonstrated enhanced sensitivity and specificity for accurate diagnosis. These developments offer the potential for earlier detection, more precise staging, and personalized treatment plans.

Conclusion: Recent advancements in early detection and diagnosis of endometrial carcinoma offer a promising outlook for improved patient outcomes. Biomarkers and imaging techniques provide valuable tools for clinicians in identifying the disease at an earlier stage, leading to timely intervention and tailored treatment strategies. However, further research and clinical validation are needed to fully integrate these innovations into routine clinical practice.

Keywords: Endometrial carcinoma, early detection, diagnosis, biomarkers, imaging techniques, microRNAs, magnetic resonance imaging, positron emission tomography, personalized treatment, gynecological malignancy.